Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Manuel R. Espinoza‐Gutarra"'
Autor:
Manuel R. Espinoza‐Gutarra, Susan M. Rawl, Gerardo Maupome, Heather A. O'Leary, Robin E. Valenzuela, Caeli Malloy, Lilian Golzarri‐Arroyo, Erik Parker, Laura Haunert, David A. Haggstrom
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7470-7484 (2023)
Abstract Background Cancer is the leading cause of death for Hispanics in the USA. Screening and prevention reduce cancer morbidity and mortality. Methods This study administered a cross‐sectional web‐based survey to self‐identified Hispanic re
Externí odkaz:
https://doaj.org/article/ed58d882121f46fb8d365580774168c3
Publikováno v:
Case Reports in Hematology, Vol 2018 (2018)
CNS involvement by CLL is a rare occurrence, usually happening in the context of a transformation to a more aggressive lymphoma in what is known as Richter’s transformation. We report a patient with active CLL who developed confusion and was found
Externí odkaz:
https://doaj.org/article/efb4be19f5c1432a89a25e60d09e9fab
Autor:
Susan M. Rawl, Gerardo Maupome, Lillian Golzarri-Arroyo, Erik Parker, Heather A. O’Leary, Manuel R. Espinoza-Gutarra, Robin E. Valenzuela, Caeli Malloy, Laura Haunert, David A. Haggstrom
Purpose: Improving understanding of behaviors that increase or reduce cancer risk for different Hispanic groups is a public health priority; such knowledge is sparse in new gateway immigration locations such as Indiana. The aims of this study were to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4e0212400b49e2649b0fe548995afe5
https://doi.org/10.21203/rs.3.rs-1975976/v1
https://doi.org/10.21203/rs.3.rs-1975976/v1
Autor:
Fabiana, Perna, Manuel R, Espinoza-Gutarra, Giuseppe, Bombaci, Sherif S, Farag, Jennifer E, Schwartz
Publikováno v:
Cancer treatment and research. 183
Acute myeloid leukemia (AML) is an aggressive, clonally heterogeneous, myeloid malignancy, with a 5-year overall survival of approximately 27%. It constitutes the most common acute leukemia in adults, with an incidence of 3-5 cases per 100,000 in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3a5bce9d1b9842d1a7a3838a04fb80f6
https://pubmed.ncbi.nlm.nih.gov/35551662
https://pubmed.ncbi.nlm.nih.gov/35551662
Autor:
Fabiana Perna, Manuel R. Espinoza-Gutarra, Giuseppe Bombaci, Sherif S. Farag, Jennifer E. Schwartz
Publikováno v:
Cancer Immunotherapies ISBN: 9783030963750
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f8683cbbba0632a49fb5066ff3d3c4a
https://doi.org/10.1007/978-3-030-96376-7_8
https://doi.org/10.1007/978-3-030-96376-7_8
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PO-114
Background: Treatment of patients (pts) with Non-Small Cell Lung Cancer (NSCLC) has changed tremendously in the last few years, however, the impact of these new therapies has been uneven; with socioeconomic, ethnic and access differences impacting th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b24ee4a71dc3b843653f2088c7c8ba3f
https://doi.org/10.1158/1538-7755.disp21-po-114
https://doi.org/10.1158/1538-7755.disp21-po-114